Literature DB >> 20965983

Antiserum against the conserved nine amino acid N-terminal peptide of influenza A virus matrix protein 2 is not immunoprotective.

Marina De Filette1, Tine Ysenbaert, Kenny Roose, Michael Schotsaert, Stefan Roels, Els Goossens, Bert Schepens, Walter Fiers, Xavier Saelens.   

Abstract

The recent emergence and rapid spread of the pandemic H1N1 swine influenza virus reminded us once again of the need for a universal influenza vaccine that can elicit heterosubtypic protection. Here, we show the superior immunogenicity and immunoprotective capacity of the full-length matrix protein 2 ectodomain (M2e) peptide coupled to keyhole limpet haemocyanin (KLH) compared with the N-terminal 9 aa residues of M2e (SP1). Immunization with M2e-KLH protected mice against a lethal challenge with influenza A virus and significantly reduced weight loss and lung virus titres. In addition, passive transfer of serum raised in rabbits against M2e-KLH protected mice against a lethal influenza virus challenge, whereas serum from rabbits immunized with SP1-KLH did not. Nevertheless, immunofluorescence staining revealed that rabbit serum raised against SP1-KLH bound specifically to infected Madin-Darby canine kidney cells. We conclude that the peptide SP1 contains an immunogenic epitope that is not sufficient for immunoprotection.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20965983     DOI: 10.1099/vir.0.027086-0

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  9 in total

1.  Tetramerizing tGCN4 domain facilitates production of Influenza A H1N1 M2e higher order soluble oligomers that show enhanced immunogenicity in vivo.

Authors:  Sweety Samal; Tripti Shrivastava; Praveen Sonkusre; Zaigham Abbas Rizvi; Rajesh Kumar; Shubbir Ahmed; Preeti Vishwakarma; Naveen Yadav; Manish Bansal; Kanchana Chauhan; Sebanta Pokhrel; Supratik Das; Padmakar Tambare; Amit Awasthi
Journal:  J Biol Chem       Date:  2020-08-13       Impact factor: 5.157

2.  Protection against Influenza A Virus Challenge with M2e-Displaying Filamentous Escherichia coli Phages.

Authors:  Lei Deng; Lorena Itatí Ibañez; Veronique Van den Bossche; Kenny Roose; Sameh A Youssef; Alain de Bruin; Walter Fiers; Xavier Saelens
Journal:  PLoS One       Date:  2015-05-14       Impact factor: 3.240

3.  Antibodies against conserved antigens provide opportunities for reform in influenza vaccine design.

Authors:  Denise A Kaminski; F Eun-Hyung Lee
Journal:  Front Immunol       Date:  2011-12-16       Impact factor: 7.561

4.  Identification of a novel splice variant form of the influenza A virus M2 ion channel with an antigenically distinct ectodomain.

Authors:  Helen M Wise; Edward C Hutchinson; Brett W Jagger; Amanda D Stuart; Zi H Kang; Nicole Robb; Louis M Schwartzman; John C Kash; Ervin Fodor; Andrew E Firth; Julia R Gog; Jeffery K Taubenberger; Paul Digard
Journal:  PLoS Pathog       Date:  2012-11-01       Impact factor: 6.823

Review 5.  M2e-Based Universal Influenza A Vaccines.

Authors:  Lei Deng; Ki Joon Cho; Walter Fiers; Xavier Saelens
Journal:  Vaccines (Basel)       Date:  2015-02-13

6.  Epitope Mapping of Avian Influenza M2e Protein: Different Species Recognise Various Epitopes.

Authors:  Noor Haliza Hasan; Esmaeil Ebrahimie; Jagoda Ignjatovic; Simson Tarigan; Anne Peaston; Farhid Hemmatzadeh
Journal:  PLoS One       Date:  2016-06-30       Impact factor: 3.240

Review 7.  M2e-based universal influenza vaccines: a historical overview and new approaches to development.

Authors:  Daria Mezhenskaya; Irina Isakova-Sivak; Larisa Rudenko
Journal:  J Biomed Sci       Date:  2019-10-19       Impact factor: 8.410

8.  Universal Live-Attenuated Influenza Vaccine Candidates Expressing Multiple M2e Epitopes Protect Ferrets against a High-Dose Heterologous Virus Challenge.

Authors:  Daria Mezhenskaya; Irina Isakova-Sivak; Victoria Matyushenko; Svetlana Donina; Andrey Rekstin; Konstantin Sivak; Kirill Yakovlev; Anastasia Katelnikova; Kirill Kryshen; Valery Makarov; Larisa Rudenko
Journal:  Viruses       Date:  2021-06-30       Impact factor: 5.048

9.  Nanoclusters self-assembled from conformation-stabilized influenza M2e as broadly cross-protective influenza vaccines.

Authors:  Li Wang; Annie Hess; Timothy Z Chang; Ying-Chun Wang; Julie A Champion; Richard W Compans; Bao-Zhong Wang
Journal:  Nanomedicine       Date:  2013-08-27       Impact factor: 5.307

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.